Study: Retinoid therapy may improve vision in people with rare genetic disorderNovember 10th 2021
Investigators from the University of Maryland found that uncovering the mechanism of vision loss in Usher syndrome yields additional drug targets for eventual development of better therapies.
Developing treatment option for vision loss through transplant of photoreceptor precursorsOctober 19th 2021
In a study, investigators demonstrated the safety and therapeutic potential of clinically compliant iPSC-derived photoreceptor precursors as a cell replacement source for future clinical trials.
Landmark treatment: Cell therapy advances options for corneal endothelial diseaseOctober 13th 2021
Results from Aurion Biotech's IOTA trial reveals that a corneal endothelial cell therapy showed improvements in visual acuity and central corneal thickness, according to a team of Japanese investigators.
Companies announce eye care collaborationSeptember 13th 2021
AbbVie and REGENXBIO announced a strategic partnership to develop and commercialize RGX-314, an investigational gene therapy for wet age-related macular degeneration, diabetic retinopathy and other chronic retinal diseases.
Study finds lasting immunity and protection from COVID-19 by single-shot, room-temperature, stable vaccineSeptember 9th 2021
The gene-based AAVCOVID vaccine employs a unique adeno-associated viral vector technology that was shown in non-clinical, nonhuman primate studies to enable protection from SARS-CoV-2 challenge and to induce sustained antibody and cellular immune responses from a single dose for up to a year.
Study: Gene therapy could preserve vision in patients with retinal disease, serious retinal injuryJuly 28th 2021
Investigators uncovered evidence that CaMKII could prove to be a desirable therapeutic target for vision preservation in conditions that damage the axons and somas of retinal ganglion cells.